Global Human cytomegalovirus 65 kDa Phosphoprotein Market Insights, Forecast to 2028

Table Of Contents

1 Study Coverage

1.1 Human cytomegalovirus 65 kDa Phosphoprotein Product Introduction 1.2 Market by Type 1.2.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 HB-101 1.2.3 CyMVectin 1.2.4 ASP-0113 1.2.5 PepVax 1.2.6 Others 1.3 Market by Application 1.3.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Brain Tumor 1.3.3 Hemotaological Tumor 1.3.4 Kidney Transplant Rejection 1.3.5 Liver Transplant Rejection 1.3.6 Others 1.4 Study Objectives 1.5 Years Considered2 Executive Summary 2.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Estimates and Forecasts 2017-2028 2.2 Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue Estimates and Forecasts 2017-2028 2.3 Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Region: 2017 VS 2021 VS 2028 2.4 Global Human cytomegalovirus 65 kDa Phosphoprotein Sales by Region 2.4.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Sales by Region (2017-2022) 2.4.2 Global Sales Human cytomegalovirus 65 kDa Phosphoprotein by Region (2023-2028) 2.5 Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Region 2.5.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Region (2017-2022) 2.5.2 Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Region (2023-2028) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa3 Competition by Manufacturers 3.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Sales by Manufacturers 3.1.1 Global Top Human cytomegalovirus 65 kDa Phosphoprotein Manufacturers by Sales (2017-2022) 3.1.2 Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Human cytomegalovirus 65 kDa Phosphoprotein in 2021 3.2 Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Manufacturers 3.2.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Manufacturers (2017-2022) 3.2.2 Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Manufacturers (2017-2022) 3.2.3 Global Top 10 and Top 5 Companies by Human cytomegalovirus 65 kDa Phosphoprotein Revenue in 2021 3.3 Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Price by Manufacturers (2017-2022) 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Human cytomegalovirus 65 kDa Phosphoprotein Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Human cytomegalovirus 65 kDa Phosphoprotein Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans4 Market Size by Type 4.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Sales by Type 4.1.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Historical Sales by Type (2017-2022) 4.1.2 Global Human cytomegalovirus 65 kDa Phosphoprotein Forecasted Sales by Type (2023-2028) 4.1.3 Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Type (2017-2028) 4.2 Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Type 4.2.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Historical Revenue by Type (2017-2022) 4.2.2 Global Human cytomegalovirus 65 kDa Phosphoprotein Forecasted Revenue by Type (2023-2028) 4.2.3 Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Type (2017-2028) 4.3 Global Human cytomegalovirus 65 kDa Phosphoprotein Price by Type 4.3.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Price by Type (2017-2022) 4.3.2 Global Human cytomegalovirus 65 kDa Phosphoprotein Price Forecast by Type (2023-2028)5 Market Size by Application 5.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Sales by Application 5.1.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Historical Sales by Application (2017-2022) 5.1.2 Global Human cytomegalovirus 65 kDa Phosphoprotein Forecasted Sales by Application (2023-2028) 5.1.3 Global Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share by Application (2017-2028) 5.2 Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Application 5.2.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Historical Revenue by Application (2017-2022) 5.2.2 Global Human cytomegalovirus 65 kDa Phosphoprotein Forecasted Revenue by Application (2023-2028) 5.2.3 Global Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share by Application (2017-2028) 5.3 Global Human cytomegalovirus 65 kDa Phosphoprotein Price by Application 5.3.1 Global Human cytomegalovirus 65 kDa Phosphoprotein Price by Application (2017-2022) 5.3.2 Global Human cytomegalovirus 65 kDa Phosphoprotein Price Forecast by Application (2023-2028)6 North America 6.1 North America Human cytomegalovirus 65 kDa Phosphoprotein Market Size by Type 6.1.1 North America Human cytomegalovirus 65 kDa Phosphoprotein Sales by Type (2017-2028) 6.1.2 North America Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Type (2017-2028) 6.2 North America Human cytomegalovirus 65 kDa Phosphoprotein Market Size by Application 6.2.1 North America Human cytomegalovirus 65 kDa Phosphoprotein Sales by Application (2017-2028) 6.2.2 North America Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Application (2017-2028) 6.3 North America Human cytomegalovirus 65 kDa Phosphoprotein Market Size by Country 6.3.1 North America Human cytomegalovirus 65 kDa Phosphoprotein Sales by Country (2017-2028) 6.3.2 North America Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Country (2017-2028) 6.3.3 U.S. 6.3.4 Canada7 Europe 7.1 Europe Human cytomegalovirus 65 kDa Phosphoprotein Market Size by Type 7.1.1 Europe Human cytomegalovirus 65 kDa Phosphoprotein Sales by Type (2017-2028) 7.1.2 Europe Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Type (2017-2028) 7.2 Europe Human cytomegalovirus 65 kDa Phosphoprotein Market Size by Application 7.2.1 Europe Human cytomegalovirus 65 kDa Phosphoprotein Sales by Application (2017-2028) 7.2.2 Europe Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Application (2017-2028) 7.3 Europe Human cytomegalovirus 65 kDa Phosphoprotein Market Size by Country 7.3.1 Europe Human cytomegalovirus 65 kDa Phosphoprotein Sales by Country (2017-2028) 7.3.2 Europe Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Country (2017-2028) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia8 Asia Pacific 8.1 Asia Pacific Human cytomegalovirus 65 kDa Phosphoprotein Market Size by Type 8.1.1 Asia Pacific Human cytomegalovirus 65 kDa Phosphoprotein Sales by Type (2017-2028) 8.1.2 Asia Pacific Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Type (2017-2028) 8.2 Asia Pacific Human cytomegalovirus 65 kDa Phosphoprotein Market Size by Application 8.2.1 Asia Pacific Human cytomegalovirus 65 kDa Phosphoprotein Sales by Application (2017-2028) 8.2.2 Asia Pacific Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Application (2017-2028) 8.3 Asia Pacific Human cytomegalovirus 65 kDa Phosphoprotein Market Size by Region 8.3.1 Asia Pacific Human cytomegalovirus 65 kDa Phosphoprotein Sales by Region (2017-2028) 8.3.2 Asia Pacific Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Region (2017-2028) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 8.3.12 Philippines9 Latin America 9.1 Latin America Human cytomegalovirus 65 kDa Phosphoprotein Market Size by Type 9.1.1 Latin America Human cytomegalovirus 65 kDa Phosphoprotein Sales by Type (2017-2028) 9.1.2 Latin America Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Type (2017-2028) 9.2 Latin America Human cytomegalovirus 65 kDa Phosphoprotein Market Size by Application 9.2.1 Latin America Human cytomegalovirus 65 kDa Phosphoprotein Sales by Application (2017-2028) 9.2.2 Latin America Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Application (2017-2028) 9.3 Latin America Human cytomegalovirus 65 kDa Phosphoprotein Market Size by Country 9.3.1 Latin America Human cytomegalovirus 65 kDa Phosphoprotein Sales by Country (2017-2028) 9.3.2 Latin America Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Country (2017-2028) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina10 Middle East and Africa 10.1 Middle East and Africa Human cytomegalovirus 65 kDa Phosphoprotein Market Size by Type 10.1.1 Middle East and Africa Human cytomegalovirus 65 kDa Phosphoprotein Sales by Type (2017-2028) 10.1.2 Middle East and Africa Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Type (2017-2028) 10.2 Middle East and Africa Human cytomegalovirus 65 kDa Phosphoprotein Market Size by Application 10.2.1 Middle East and Africa Human cytomegalovirus 65 kDa Phosphoprotein Sales by Application (2017-2028) 10.2.2 Middle East and Africa Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Application (2017-2028) 10.3 Middle East and Africa Human cytomegalovirus 65 kDa Phosphoprotein Market Size by Country 10.3.1 Middle East and Africa Human cytomegalovirus 65 kDa Phosphoprotein Sales by Country (2017-2028) 10.3.2 Middle East and Africa Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Country (2017-2028) 10.3.3 Turkey 10.3.4 Saudi Arabia11 Company Profiles 11.1 Astellas Pharma Inc 11.1.1 Astellas Pharma Inc Corporation Information 11.1.2 Astellas Pharma Inc Overview 11.1.3 Astellas Pharma Inc Human cytomegalovirus 65 kDa Phosphoprotein Sales, Price, Revenue and Gross Margin (2017-2022) 11.1.4 Astellas Pharma Inc Human cytomegalovirus 65 kDa Phosphoprotein Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Astellas Pharma Inc Recent Developments 11.2 Hookipa Biotech AG 11.2.1 Hookipa Biotech AG Corporation Information 11.2.2 Hookipa Biotech AG Overview 11.2.3 Hookipa Biotech AG Human cytomegalovirus 65 kDa Phosphoprotein Sales, Price, Revenue and Gross Margin (2017-2022) 11.2.4 Hookipa Biotech AG Human cytomegalovirus 65 kDa Phosphoprotein Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 Hookipa Biotech AG Recent Developments 11.3 Immunomic Therapeutics Inc 11.3.1 Immunomic Therapeutics Inc Corporation Information 11.3.2 Immunomic Therapeutics Inc Overview 11.3.3 Immunomic Therapeutics Inc Human cytomegalovirus 65 kDa Phosphoprotein Sales, Price, Revenue and Gross Margin (2017-2022) 11.3.4 Immunomic Therapeutics Inc Human cytomegalovirus 65 kDa Phosphoprotein Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Immunomic Therapeutics Inc Recent Developments 11.4 Vakzine Projekt Management GmbH 11.4.1 Vakzine Projekt Management GmbH Corporation Information 11.4.2 Vakzine Projekt Management GmbH Overview 11.4.3 Vakzine Projekt Management GmbH Human cytomegalovirus 65 kDa Phosphoprotein Sales, Price, Revenue and Gross Margin (2017-2022) 11.4.4 Vakzine Projekt Management GmbH Human cytomegalovirus 65 kDa Phosphoprotein Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 Vakzine Projekt Management GmbH Recent Developments 11.5 Vaximm AG 11.5.1 Vaximm AG Corporation Information 11.5.2 Vaximm AG Overview 11.5.3 Vaximm AG Human cytomegalovirus 65 kDa Phosphoprotein Sales, Price, Revenue and Gross Margin (2017-2022) 11.5.4 Vaximm AG Human cytomegalovirus 65 kDa Phosphoprotein Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 Vaximm AG Recent Developments 11.6 VBI Vaccines Inc 11.6.1 VBI Vaccines Inc Corporation Information 11.6.2 VBI Vaccines Inc Overview 11.6.3 VBI Vaccines Inc Human cytomegalovirus 65 kDa Phosphoprotein Sales, Price, Revenue and Gross Margin (2017-2022) 11.6.4 VBI Vaccines Inc Human cytomegalovirus 65 kDa Phosphoprotein Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 VBI Vaccines Inc Recent Developments 11.7 Vical Inc 11.7.1 Vical Inc Corporation Information 11.7.2 Vical Inc Overview 11.7.3 Vical Inc Human cytomegalovirus 65 kDa Phosphoprotein Sales, Price, Revenue and Gross Margin (2017-2022) 11.7.4 Vical Inc Human cytomegalovirus 65 kDa Phosphoprotein Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 Vical Inc Recent Developments12 Industry Chain and Sales Channels Analysis 12.1 Human cytomegalovirus 65 kDa Phosphoprotein Industry Chain Analysis 12.2 Human cytomegalovirus 65 kDa Phosphoprotein Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Human cytomegalovirus 65 kDa Phosphoprotein Production Mode & Process 12.4 Human cytomegalovirus 65 kDa Phosphoprotein Sales and Marketing 12.4.1 Human cytomegalovirus 65 kDa Phosphoprotein Sales Channels 12.4.2 Human cytomegalovirus 65 kDa Phosphoprotein Distributors 12.5 Human cytomegalovirus 65 kDa Phosphoprotein Customers13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Human cytomegalovirus 65 kDa Phosphoprotein Industry Trends 13.2 Human cytomegalovirus 65 kDa Phosphoprotein Market Drivers 13.3 Human cytomegalovirus 65 kDa Phosphoprotein Market Challenges 13.4 Human cytomegalovirus 65 kDa Phosphoprotein Market Restraints14 Key Findings in The Global Human cytomegalovirus 65 kDa Phosphoprotein Study15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer